Evaluation of KRAS mutation subtype on survival in patients with metastatic non-small cell lung cancer receiving immunotherapy

被引:0
|
作者
Barron, C. C. [1 ]
Kuang, S. [1 ]
Makarem, M. [1 ]
Elliott, M. J. [1 ]
Sharma, K. [1 ]
Lee, J. [1 ]
Schmid, S. [1 ]
Rabinovitch, A. [1 ]
Bradbury, P. [1 ]
Liu, G. [1 ]
Shepherd, F. A. [1 ]
Tsao, M. S. [1 ]
Leighl, N. [1 ]
Rose, A. [2 ]
Pezo, R. [3 ]
Doherty, M. [4 ]
Cheng, S. [3 ]
Lau, S. C. [1 ]
Sacher, A. [1 ]
机构
[1] Univ Hlth Network, Med Oncol, UHN, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Jewish Gen Hosp, Segal Canc Ctr, Med Oncol, Montreal, PQ, Canada
[3] Odette Canc Ctr, Med Oncol, Toronto, ON, Canada
[4] Beaumont Hosp, Med Oncol, Dublin, Ireland
关键词
D O I
10.1016/j.annonc.2021.08.263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1809P
引用
收藏
页码:S1229 / S1230
页数:2
相关论文
共 50 条
  • [31] Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting
    Belaroussi, Yaniss
    Bouteiller, Fanny
    Bellera, Carine
    Pasquier, David
    Perol, Maurice
    Debieuvre, Didier
    Filleron, Thomas
    Girard, Nicolas
    Schott, Roland
    Mathoulin-Pelissier, Simone
    Martin, Anne-Laure
    Cousin, Sophie
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [32] Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes"
    Aredo, Jacqueline V.
    Padda, Sukhmani K.
    Kunder, Christian A.
    Han, Summer S.
    Neal, Joel W.
    Shrager, Joseph B.
    Wakelee, Heather A.
    LUNG CANCER, 2019, 137 : 159 - 160
  • [33] Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy
    Bjornhart, Birgitte
    Kristiansen, Charlotte
    Asmussen, Jon
    Hansen, Karin Holmskov
    Wedervang, Kim
    Jorgensen, Trine Lembrecht
    Herrstedt, Jorn
    Schytte, Tine
    THROMBOSIS RESEARCH, 2023, 221 : 164 - 172
  • [34] Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy
    Maria Laura Canale
    Andrea Camerini
    Giancarlo Casolo
    Alessio Lilli
    Irma Bisceglia
    Iris Parrini
    Chiara Lestuzzi
    Jacopo Del Meglio
    Cheti Puccetti
    Lara Camerini
    Domenico Amoroso
    Nicola Maurea
    Advances in Therapy, 2020, 37 : 3178 - 3184
  • [35] Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy
    Canale, Maria Laura
    Camerini, Andrea
    Casolo, Giancarlo
    Lilli, Alessio
    Bisceglia, Irma
    Parrini, Iris
    Lestuzzi, Chiara
    Del Meglio, Jacopo
    Puccetti, Cheti
    Camerini, Lara
    Amoroso, Domenico
    Maurea, Nicola
    ADVANCES IN THERAPY, 2020, 37 (07) : 3178 - 3184
  • [36] Efficacy of immunotherapy retreatment in patients with non-small cell lung cancer receiving consolidative durvalumab
    Carroll, Allison Baker
    Kohler, Lindsay Renee
    Cipriani, Amber Britton
    Patel, Shetal Arvind
    Chen, Kevin Yanjun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
    Shen, Hong
    Cao, Ying
    Li, Xiaofen
    Tan, Yinuo
    Chen, Jiaqi
    Yang, Ziru
    Kong, Yiyao
    Yuan, Ying
    MEDICINE, 2016, 95 (21)
  • [38] Association of Mutation Profiles with Postoperative Survival in Patients with Non-Small Cell Lung Cancer
    Goto, Taichiro
    Kunimasa, Kei
    Hirotsu, Yosuke
    Nakagomi, Takahiro
    Yokoyama, Yujiro
    Higuchi, Rumi
    Otake, Sotaro
    Oyama, Toshio
    Amemiya, Kenji
    Mochizuki, Hitoshi
    Omata, Masao
    CANCERS, 2020, 12 (11) : 1 - 16
  • [39] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
    Luecke, E.
    Ganzert, C.
    Waesche, A.
    Walles, T.
    Schreiber, J.
    PNEUMOLOGIE, 2020, 74 : S74 - S75
  • [40] Association of Mutation Profiles with Postoperative Survival in Patients with Non-Small Cell Lung Cancer
    Goto, Taichiro
    Hirotsu, Yosuke
    Amemiya, Kenji
    Mochizuki, Hitoshi
    Omata, Masao
    CANCER SCIENCE, 2021, 112 : 653 - 653